Medical Condition News

RSS

LLS symposium to review latest advances in blood cancer research

A cadre of leading researchers in hematology, oncology, cell biology, and biotechnology are conducting presentations and discussions at this symposium to review the latest advances in blood cancer research.

12 Oct 2012

Results from Aldagen’s ALD-401 Phase II trial on ischemic stroke

Early results of a Phase II intra-arterial stem cell trial for ischemic stroke showed no adverse events associated with the first 10 patients, allowing investigators to expand the study to a targeted total of 100 patients.

12 Oct 2012

Two Boston University community members among new MAS Fellows

Two members of the Boston University community are among the new class of Fellows of the Massachusetts Academy of Sciences (MAS).

12 Oct 2012

Clinical study to investigate Cytori's adipose-derived cell therapy in patients with heart failure

Timothy Henry, M.D. of the Minneapolis Heart Institute Foundation treated the first patient in the ATHENA study, injecting the patient's own stem cells into the heart to restore blood flow and help regenerate heart muscle. Henry, the Foundation's Director of Research is co-principal investigator of the ATHENA study sponsored by Cytori Therapeutics.

12 Oct 2012

Regenstrief, IU to work with 19 Indiana nursing facilities to improve quality of care

A multi-million-dollar award from the Centers for Medicare & Medicaid Services, or CMS, will enable Indiana University and Regenstrief Institute clinician-researchers to work with 19 central Indiana nursing facilities to improve the quality of care, reduce hospitalizations and increase access to palliative care for long-stay nursing facility residents.

12 Oct 2012

Nelfinavir slows progress of HER2-positive tumor cells

After screening more than 2,300 drugs for their ability to halt the growth of breast cancer cells, Johns Hopkins researchers have discovered that the anti-HIV drug nelfinavir slows the progress of HER2-positive tumor cells, even if they are resistant to other breast cancer drugs.

12 Oct 2012

Protocol allows researchers to generate functional thyroid tissue from stem cells

The generation of functional thyroid tissue from stem cells could allow the treatment of patients, which suffer from thyroid hormone deficiency due to defective function, or abnormal development of the thyroid gland.

12 Oct 2012

T cells become more responsive in cancer survivors after exercise

Researchers may soon be able to add yet another item to the list of exercise's well-documented health benefits: A preliminary study suggests that when cancer survivors exercise for several weeks after they finish chemotherapy, their immune systems remodel themselves to become more effective, potentially fending off future incidences of cancer.

12 Oct 2012

AACR conference to focus on scientific and lifestyle strategies for cancer prevention

The American Association for Cancer Research will host the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research at the Hilton Anaheim from Oct. 16-19, 2012.

12 Oct 2012

NRG1 gene plays an important role in cannabis dependence

A paper by Shizhong Han and colleagues in the current issue of Biological Psychiatry implicates a new gene in the risk for cannabis dependence. This gene, NRG1, codes for the ErbB4 receptor, a protein implicated in synaptic development and function.

12 Oct 2012

Top-line results from Pfizer’s ALO-02 Phase 3 study on chronic non-cancer pain

Pfizer Inc. announced top-line results today from a Phase 3 open-label long-term safety study of investigational agent ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules) in patients with moderate-to-severe chronic, non-cancer pain.

12 Oct 2012

First picture of interaction between leptin and its receptor

Researchers at the University of Michigan have determined how the hormone leptin, an important regulator of metabolism and body weight, interacts with a key receptor in the brain.

12 Oct 2012

Investigators provide overview of role of dopamine in modulating the immune system

Dopamine is a neurotransmitter that is associated with emotions, movement, and the brain's pleasure and reward system. In the current issue of Advances in Neuroimmune Biology, investigators provide a broad overview of the direct and indirect role of dopamine in modulating the immune system and discuss how recent research has opened up new possibilities for treating diseases such as Parkinson's and Alzheimer's disease, schizophrenia, multiple sclerosis or even the autoimmune disorders.

11 Oct 2012

Study shows how CaM kinase II triggers cell death following heart damage

University of Iowa researchers have previously shown that an enzyme called CaM kinase II plays a pivotal role in the death of heart cells following a heart attack or other conditions that damage or stress heart muscle.

11 Oct 2012

Enrollment complete in Euthymics’ amitifadine phase 2b/3a trial for major depressive disorder

Euthymics Bioscience, Inc. today announced completion of enrollment in the advanced clinical study of its lead product candidate amitifadine (formerly called EB-1010), a novel serotonin-preferring triple reuptake inhibitor for the treatment of major depressive disorder (MDD).

11 Oct 2012

Amarantus acquires option to license LymPro Alzheimer's diagnostic blood test from MDx

Amarantus BioSciences, Inc., a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptotis therapeutic protein MANF, today announced that it has acquired an exclusive option to license the LymPro Alzheimer's Diagnostic Blood Test from Memory Dx, LLC (MDx), formerly known as Provista Life Sciences, LLC.

11 Oct 2012

CEO Roundtable on Cancer's Life Sciences Consortium initiates Project Data Sphere

The CEO Roundtable on Cancer's Life Sciences Consortium has initiated Project Data Sphere, a collaborative effort to create a shared platform where clinical trials data will become available to researchers for further studies that will speed cancer research.

11 Oct 2012

Researchers create mouse model that reproduces brain chemical changes associated with AD

Researchers at Western University have created a mouse model that reproduces some of the chemical changes in the brain that occur with Alzheimer's, shedding new light on this devastating disease.

11 Oct 2012

New York Stem Cell Foundation names 6 scientists as 2012 NYSCF - Robertson Investigators

The New York Stem Cell Foundation (NYSCF) named six of the most promising scientists as its 2012 NYSCF - Robertson Investigators.

11 Oct 2012

Novel neuroimaging technique reveals evidence of cocaine-induced cerebral microischemia

Researchers from the Department of Biomedical Engineering at Stony Brook University have developed a high-resolution, 3D optical Doppler imaging tomography technique that captures the effects of cocaine restricting the blood supply in vessels - including small capillaries - of the brain.

11 Oct 2012

Medical Condition News

LLS symposium to review latest advances in blood cancer research

Results from Aldagen’s ALD-401 Phase II trial on ischemic stroke

Two Boston University community members among new MAS Fellows

Clinical study to investigate Cytori's adipose-derived cell therapy in patients with heart failure

Regenstrief, IU to work with 19 Indiana nursing facilities to improve quality of care

Nelfinavir slows progress of HER2-positive tumor cells

Protocol allows researchers to generate functional thyroid tissue from stem cells

T cells become more responsive in cancer survivors after exercise

AACR conference to focus on scientific and lifestyle strategies for cancer prevention

NRG1 gene plays an important role in cannabis dependence

Top-line results from Pfizer’s ALO-02 Phase 3 study on chronic non-cancer pain

First picture of interaction between leptin and its receptor

Investigators provide overview of role of dopamine in modulating the immune system

Study shows how CaM kinase II triggers cell death following heart damage

Enrollment complete in Euthymics’ amitifadine phase 2b/3a trial for major depressive disorder

Amarantus acquires option to license LymPro Alzheimer's diagnostic blood test from MDx

CEO Roundtable on Cancer's Life Sciences Consortium initiates Project Data Sphere

Researchers create mouse model that reproduces brain chemical changes associated with AD

New York Stem Cell Foundation names 6 scientists as 2012 NYSCF - Robertson Investigators

Novel neuroimaging technique reveals evidence of cocaine-induced cerebral microischemia

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News